

ACC CardiaCast
American College of Cardiology
This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.
Episodes
Mentioned books

Oct 3, 2025 • 13min
PulseCheck: CV Care in Pregnancy: The Essentials
Explore the rising importance of cardio-obstetrics as cardiovascular disease becomes more common in pregnancy. Discover how these conditions affect maternal health and can reveal hidden risks. Learn the value of interdisciplinary teams that include various specialists to ensure comprehensive care. Clinicians are urged to take detailed reproductive histories to better identify risks. Plus, gain practical tips for managing pregnant patients, like anticipating arrhythmias and collaborating across disciplines.

Oct 2, 2025 • 16min
2024 ACC Expert Consensus Decision Pathway for Treatment of HFrEF
In this episode, Vanessa Blumer, MD, FACC, and Ersilia M. DeFilippis, MD, FACC, discuss the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction (HFrEF). Learners will hear guidance on how to implement a structured multidisciplinary HF approach that improves clinical and patient-centered outcomes. This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here. Subscribe to CardiaCast

Sep 25, 2025 • 14min
GDMT Will Not Delay HF Treatment
In this episode, Michelle M. Kittleson, MD, PhD, FACC, and Estefania Oliveros Soles, MD, MSc, FACC discuss challenges in heart failure (HF) care, focusing on utilization of guideline-directed medical therapy (GDMT). Learners will hear tips on how to add and maximize GDMT in patients with HF. This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here. Subscribe to CardiaCast

Sep 22, 2025 • 21min
Innovation in Action: AI-Enabled ECG: From Concept to Clinical Care
Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed to explore innovations shaping care delivery. In this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation. The discussion also covers strategies for evaluating AI solutions and best practices for integrating them into clinical workflows. This podcast is supported by Anumana.

Sep 15, 2025 • 22min
Courtside With The Chair: CV Care of the Masters Athlete – Part 1
"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan H. Kim is joined by Drs. Eugene H. Chung, Ankit B. Shah, and Jeffrey J. Hsu to discuss the cardiovascular care of the masters athlete. Subscribe to CardiaCast |

10 snips
Aug 15, 2025 • 21min
Innovation in Action: Addressing Unmet Needs in Thrombotic Conditions
Dr. Roxana Mehran, a renowned cardiologist and clinical trial leader, joins Dr. Carolyn Lam, an esteemed academic leader in women's heart health, for a compelling discussion. They delve into the global impact of thrombotic conditions, accounting for a quarter of deaths worldwide. The pair explore current treatments, the risks of bleeding, and innovative strategies targeting factor XI to enhance patient outcomes. They also highlight the Milvexian trials and share insights on equitable access to new therapies, while encouraging young clinician-scientists to embrace mentorship.

Aug 8, 2025 • 33min
Conversations with Critical Care Cardiologists: Show Me the Evidence
Straight from ACC.25, this episode dives into the latest science shaping the care of patients in shock. Join Drs. Shashank Sinha, Ann Gage, Anthony Carnicelli, and David Berg—leading voices in critical care cardiology—as they break down the Altshock-2 study, explore updates from the 2025 ACS Guidelines, and highlight key takeaways from the newly released 2025 ACC Shock Guidance. Whether you're managing patients in the cardiac intensive care unit or leading your heart team through complex cases, this high-yield discussion offers sharp insights, clinical pearls, and evidence you can apply today. Subscribe to CardiaCast | Claim CME Credit

Jun 27, 2025 • 22min
Highlights from EuroPCR 2025
In this inaugural episode of the new podcast series produced by ACC's Interventional Member Section, Dr. Poonam Velagapudi is joined by featured guests Drs. Debabrata Dash and Thomas Cuisset to discuss the Highlights from EuroPCR 2025. Explore key insights from the 4D-ACS trial, followed by a discussion on its practical impact in clinical settings. The discussants examine the FAITAVI trial, highlighting major findings and their influence on procedural decision-making. A recent meta-analysis is also reviewed, with commentary on how the collective evidence may shape real-world interventional strategies. Tune in for a dynamic exchange on cutting-edge trials and their implications for the cath lab. Related References: The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data (PCR Online). 2025. Available at: https://www.pcronline.com/News/PCR-Press-Releases/2025/EuroPCR-2025-The-FAITAVI-trial-angiography-versus-physiology-guided-PCI-in-patients-undergoing-TAVI-12-month-follow-up-data. Accessed 6/24/25. Ribichini F, Pesarini G, Fabris T, et al. A randomised multicentre study of angiography- versus physiologyguided percutaneous coronary intervention in patients with coronary artery disease undergoing TAVI: design and rationale of the FAITAVI trial. EuroIntervention. 2024 Apr 15;20(8):e504-e510. doi: 10.4244/EIJ-D-23-00679. Jang Y, Park SD, Lee JP, et al. One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial. EuroIntervention. 2025 May 21:EIJ-D-25-00331. doi: 10.4244/EIJ-D-25-00331. Subscribe to CardiaCast | Claim CME Credit

Jun 23, 2025 • 21min
Moving the Needle: Clinical Strategies focusing on Controlling LDL-C
In this episode of CardiaCast, Drs. Erin Michos and Joseph Saseen discuss the underuse of lipid-lowering therapies in patients with cardiovascular risk, despite strong evidence and updated guidelines. They highlight the role of bempedoic acid as a non-statin option, especially for statin-intolerant patients. The conversation emphasizes team-based care, shared decision-making, and strategies to navigate insurance barriers to improve LDL-C management. This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative. Educational grant support is provided by Esperion. Related References Nelson A, Haynes K, Shambhu S, et al. High-intensity statin use among patients with atherosclerosis in the U.S. J Am Coll Cardiol. 2022;79(18):1802–1813. doi:10.1016/j.jacc.2022.02.048 Cannon CP, de Lemos JA, Rosenson RS, et al. Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US. JAMA Cardiol. 2021;6(9):1060–1068. doi:10.1001/jamacardio.2021.1810 Worledge EA, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. Published online April 11, 2025. doi:10.1016/j.jacl.2025.04.186 Subscribe to CardiaCast

Jun 20, 2025 • 12min
SCAI 2025 Think Tank Session Highlights: Radiation Protection and Team Well-Being
In this episode Drs. Poonam Velagapudi, Saraschandra Vallabhajosyula, and James Hermiller explore the critical topic of occupational safety in the cath lab. While healthcare providers focus on treating patients, their work environment can put their own health at risk—particularly long-term impact of wearing heavy lead protection. Drawing from discussions at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Think Tank Sessions, the episode highlights data on lead-free and reduced-lead solutions aimed at preventing back pain and injury among cardiac catheterization operators. Tune in for a timely conversation on protecting the well-being of the heart team. Related References Strepkos D, Rempakos A, Alexandrou M, et al. How to Improve Radiation Protection in Interventional Cardiology Procedures. Circ Cardiovasc Interv. 2025;18(4):e014808. doi:10.1161/CIRCINTERVENTIONS.124.014808 Women in Innovations (WIN) Radiation Safety (SCAI website). 2025. Available at: https://scai.org/membership/career-development/women-innovations-win/win-radiation-safety . Accessed 06/17/25. SCAI Highlights Cath Lab Radiation and Orthopaedic Hazards (Cardiovascular News website). Available at: https://cardiovascularnews.com/scai-highlights-cath-lab-radiation-and-orthopaedic-hazards/. Accessed 06/17/25. Occupational Health Hazards in the Cardiac Catheterization Laboratory (SCAI website). 2025. Available at: https://scai.org/occupational-health-hazards-cardiac-catheterization-laboratory . Accessed 06/17/25. Subscribe to CardiaCast | Claim CME Credit


